Cancer Advances
Subscribe:
Featured Episode
New Cell Therapies May Hold Key to Treatment of Advanced and Rare Skin Cancers
Brian Gastman, MD, Surgical and Co-Director of Cleveland Clinic's Melanoma and High-Risk Skin Cancer Program joins the Cancer Advances podcast to discuss Merkel cell carcinoma (MCC). Listen as Dr. Gastman discusses clinical trials exploring the use of immunotherapy with adoptive cell transfer for advanced melanoma and Merkel cell carcinoma.
Play NowAll Cancer Advances Episodes
January 13, 2022
Liquid Biopsy in Breast Cancer
Chief of Breast Surgery at Cleveland Clinic Cancer Center, Julie Lang, MD, joins the Cancer Advances podcast to discuss liquid biopsies in breast cancer. Listen as Dr. Lang discusses how liquid biopsies have been used in the past and how she using them in a new study, funded in part by VeloSano. The study will use next generation sequencing to detect circulating tumor DNA in the blood samples, and to try to improve upon an existing assay based on biomarkers that may be secreted by different types of tumors, benign and malignant.
Play NowJanuary 6, 2022
Patient and Family Support Services
At Cleveland Clinic, exceptional cancer care is complemented by services that address the emotional, psycho-social, and financial needs of our patients. Melanie Robbins-Ong, DO, palliative and supportive care specialist at Cleveland Clinic Cancer Center joins the Cancer Advances podcast to discuss the importance of patient and family support services. Listen as Dr. Robbins-Ong describes the different types of services we offer not only for our patients but also for their families and care partners.
Play NowDecember 23, 2021
POEMS: A Rare, Often Misdiagnosed and Disabling Condition if Not Properly Treated
Jack Khouri, MD, hematologist oncologist at Cleveland Clinic Cancer Center, who specializes in rare plasma cell disorders within the Rare Cancers and Blood Diseases program joins the Cancer Advances podcast to discuss POEMS (i.e., polyneuropathy, organomegaly, endocrinopathy, monoclonal gammopathy and skin changes). Listen as Dr. Khouri talks about how the early recognition and diagnosis of POEMS is key to effective management.
Play NowDecember 16, 2021
Biosignature Predicts Benefit of Adjuvant Radiotherapy in Patients With DCIS
Results from a multi-institutional study led by a Cleveland Clinic researcher, DCSionRT, a biosignature based on multiple biomarkers, may hold the key to solving the treatment of ductal carcinoma in situ (DCIS). Chirag Shah, MD, coinvestigator, and director of Breast Radiation Oncology at Cleveland Clinic joins the Cancer Advances podcast to explain the study and findings that were presented at the American Society for Radiation Oncology annual meeting (ASTRO).
Play Now
